Additional information
| Active substance | Survodutide |
|---|---|
| Hepatotoxicity | No significant hepatotoxicity reported |
| Lab Test | Monitoring blood glucose levels and HbA1c |
| Also known as | LY3298176 |
| Blood pressure | May reduce blood pressure |
| Trade name | Mounjaro |
| FORM | 1 vial x 10 mg |
| Storage conditions | Store in a refrigerator at 2В°C to 8В°C (36В°F to 46В°F), protect from light |
| Chemical name | Tirzepatide |
| Formula | C225H348N48O68 |
| Substance class | Glucagon-like peptide-1 (GLP-1) receptor agonists |
| Main action | Lowers blood glucose levels |
| Half-life | Approximately 5 days |
| Dosage (medical) | Typically started at 2.5 mg once weekly, can be increased to 5 mg, 10 mg, or 15 mg once weekly depending on response and tolerability |
| Dosage (sports) | Not applicable as it is not used for performance enhancement |
| Effects | Improves glycemic control, promotes weight loss |
| Side effects | Nausea, diarrhea, decreased appetite, vomiting, constipation |
| Use in sports | None, not used for performance enhancement |
| Manufacturer | Dragon Pharma |
Balkan Pharma Danabol 50 mg 60 Tabletten
Alpha Pharma Rexogin 50 mg 10 Ampere
Tavanic 500 mg Sanofi
Prograf 5mg Astellas Pharma
Balkan Pharma Turanabol 10 mg 60 Tabletten
Norvacs 10 mg Pfizer
Balkan Pharma Strombafort 10mg 100 Tabletten
Alpha Pharma Testobolin 250mg 10 Amp- Depot
TC-200 INTEX PHARMA 

Reviews
There are no reviews yet.